• Home  /
  • Research & Analysis   /
  • Wallstreet Hotties of the Day: Matador Resources Company (NYSE:MTDR), The Clorox Company (NYSE:CLX)

Wallstreet Hotties of the Day: Matador Resources Company (NYSE:MTDR), The Clorox Company (NYSE:CLX)

Matador Resources Company (NYSE:MTDR)

The shares of Matador Resources Company (NYSE:MTDR) started off the last trading session with the price of $28.57 while closing the day with the price of $28.87. The shares of Matador Resources Company (NYSE:MTDR) Rise 1.23% with the Gain of 0.3 points.

The shares of Matador Resources Company (NYSE:MTDR) traded with the day volume of 1.46 Million shares whereas its average trading volume is 1.2 Million.

While analyzing the past performance of the stock we can see that the shares of Matador Resources Company (NYSE:MTDR) Loss -1.57% in the last week while Falling -2.37% in the last month. Past quarter performance shows the green light with 5.94%. The semi-annual and annual performance shows 20.59% and 24.12% respectively.

Some critical values of the shares of Matador Resources Company (NYSE:MTDR) to be discussed here are: the beta which shows the value at 1.25 while Average True Range of Matador Resources Company (NYSE:MTDR) demonstrate the value at 1.1. The weekly and monthly volatility of the shares of Matador Resources Company (NYSE:MTDR) are indicated at 2.77% and 3.68%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 45.52.

While studying the financial position of the shares of Matador Resources Company (NYSE:MTDR), we can see that the Market capitalization of the company is at 3.09 Billion. The shares outstanding for the company is 107.13 Million and the shares float stands at 96.31 Million. The income of the company stand at 177.4 Million while the sales stand at 548.6 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.7, Price to Earnings or P/E is at 16.97, Price to Sales P/S show the value of 5.64, the Return on Asset ROA stood at 0.068 and the Return on Equity ROE depicted at 0.132 while Return on Investment ROI is at 0.127.


The Clorox Company (NYSE:CLX)

The Clorox Company (NYSE:CLX) started its previous trading session at $127.25 and closed at $128.49 showing a Rise of 1.06 Percent.

The Company traded with an average Volume of 1.04 Million whereas, its Day Volume stood at 1.45 Million.

Looking at the performance of the stock, The Clorox Company (NYSE:CLX) Loss -2.34% in the last week in its shares price and -0.24% in the last month. Quarterly performance shows a red of -12.36 Percent while Semi-Annual and Annual performances shows a -4.64 and -6.9 percent respectively.

Beta for The Clorox Company (NYSE:CLX) stands at 0.36 while the ATR (average true range) is at 2.65. The Stock’s Weekly and Monthly Volatility is 1.84% and 1.91% respectively showing a RSI value of 42.25.

While studying the financial position of the shares of The Clorox Company (NYSE:CLX), we can see that the Market capitalization of the company is at 16.62 Billion. The shares outstanding for the company is 129.36 Million and the shares float stands at 129.27 Million.

The Company generated an income of 718 Million and the sales of 6.04 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $5.45 a share. P/E (price to earnings) and P/S (price to sales) values are 23.56 and 2.75 respectively.

The Return on Assets stands at 0.172, ROE shows a value of 1.389 and ROI for The Clorox Company (NYSE:CLX) is 0.257 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment